Infant Formula Botulism Alert
Nara Organics Recalls Baby Formula Sold at Target After Infant Botulism Outbreak Sickens Three Babies
Anonymous
Nara Organics has recalled its Whole Milk Organic Powdered Infant Formula after three babies aged 2 to 5 months became sick with botulism in California, Pennsylvania, and Washington. All three infants were hospitalized and treated with BabyBIG®, the only approved medication for the illness, according to CDC.
The formula is sold at Target stores, Target.com, and Nara.com. The CDC is urging parents to stop using the product immediately. Do not throw it away — store it in a safe place labeled "DO NOT USE," as health officials need samples for testing, AP reported.
How Three Sick Babies Triggered a Nationwide Recall
Infants in three states began showing botulism symptoms between April and May 2026. The last known illness onset was May 31, 2026, according to Lynnwood Times. California's Infant Botulism Treatment and Prevention Program identified the cluster and alerted federal authorities.
On June 12, the FDA gave Nara Organics data linking all three cases to its formula. By June 13, the FDA recommended a recall based on what it called an "epidemiological signal" — meaning every sick infant had consumed this specific product. Nara agreed to a voluntary nationwide recall that same afternoon, LiveNOW from FOX reported.
What Infant Botulism Is and Why Babies Are Vulnerable
Infant botulism is rare but life-threatening. It happens when a baby swallows spores of the bacteria Clostridium botulinum. The spores grow inside the baby's immature gut and release a toxin that causes muscle weakness. Warning signs include constipation, a weak cry, and drooping eyelids, according to CDC.
Babies under one year old are most at risk because their digestive systems are not fully developed. The only approved treatment is BabyBIG®, given through an IV. Nara Organics says no sample of its formula has tested positive for the bacteria yet. The FDA, however, says the epidemiological link is strong enough to act now, according to AP.
16 Lot Codes Recalled — No Formula Shortage Expected
The recall covers 16 specific lot codes, including codes starting with "408," "708," "709," and "409," distributed nationwide from July 2025 through June 2026, according to eFoodAlert. The formula is made in Germany but sold only in the United States. Nara has paused all U.S. sales and is issuing automatic refunds for May and June orders.
Parents should not panic about finding replacement formula. Nara Organics accounts for less than 1% of all infant formula sold in the U.S. Federal officials say the recall will not cause a supply shortage like the 2022 Abbott crisis, AP reported. Target is processing returns and refunds at all store locations.
A Second Botulism Outbreak in Seven Months Raises Red Flags
This is not the first time a premium infant formula has been linked to botulism. In November 2025, formula brand ByHeart was connected to 48 hospitalizations — 28 confirmed and 20 probable — across 17 states, with zero deaths, according to FDA archives. No criminal charges or major regulatory changes followed that outbreak.
Food safety attorney Bill Marler called this "the second formula-linked infant botulism outbreak in seven months." He argued that boutique brands marketing "clean" or "EU-standard" ingredients may be moving faster than safety protocols can keep up. Food Poison Journal reported that Marler is now calling for stricter FDA oversight of European contract manufacturers that supply imported formula to U.S. markets.
Sentiment
NeutralNEGATIVENEUTRALPOSITIVE
Publishers
27
Articles
27
Reach
27
A
AnonymousAuthor
